Table 2.
In vitro mycelium inhibition efficacy of CSGA nanocomposites.
| Fungus | Nanoformulation with Mancozeb (ppm) | CSGA NCs | CSGA NCs% Inhibition = dc − dt/dc × 100 |
Mancozeb (ppm) | Mancozeb | Mancozeb% Inhibition = dc − dt/dc × 100 |
|---|---|---|---|---|---|---|
| Fungus Diameter (mm) | Fungus Diameter (mm) | |||||
|
A. solani (ITCC3640) |
Blank NC, N 1.0 | 22.5 ± 0.6 | 65.4 ± 0.7c | - | - | - |
| Loaded NC, NF 0.5 | 17.5 ± 0.7 | 73.1 ± 1.2bc | F 0.5 | 10.5 ± 0.5 | 83.8 ± 0.7b | |
| Loaded NC, NF 1.0 | 17.0 ± 0.5 | 75.8 ± 1.4bc | F 1.0 | 10 ± 0.8 | 84.6 ± 0b | |
| Loaded NC, NF 1.5 | 10.5 ± 0.8 | 83.8 ± 0.7b | F 1.5 | 10 ± 0.6 | 84.6 ± 0b | |
|
S. sclerotiorum (ITCC5492) |
Blank NC, N 1.0 | 12.5 ± 0.8 | 63.2 ± 0.7c | - | - | - |
| Loaded NC, NF 0.5 | 13.0 ± 0.9 | 59.9 ± 1.4c | F 0.5 | 10.5 ± 0.7 | 69.1 ± 0.7c | |
| Loaded NC, NF 1.0 | 0 | 100 ± 0a | F 1.0 | 0 | 100 ± 0a | |
| Loaded NC, NF 1.5 | 0 | 100 ± 0a | F 1.5 | 0 | 100 ± 0a |
Each value is the average of three measurements. A t-test found that mean ± SD followed by the same letter in the treatment column are not statistically different from control at p ≤ 0.05.